Drug Profile
Research programme: Notch1 modulators - Andarix Pharmaceuticals/Tulane University
Latest Information Update: 28 Nov 2019
Price :
$50
*
At a glance
- Originator Tulane University
- Developer Andarix Pharmaceuticals; Tulane University
- Class
- Mechanism of Action Notch receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Nov 2019 No recent reports of development identified for research development in Cancer in USA
- 20 Oct 2015 Early research in Cancer in USA (unspecified route)